Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
90 participants
INTERVENTIONAL
2013-08-31
2014-02-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Efficacy and Safety of Remimazolam in General Anesthesia in Adults Undergoing Cardiac Surgery
NCT02523859
Safety and Efficacy of Remimazolam in OPCAB Surgery
NCT05396690
Remimazolam vs. Midazolam for Sedation and Cognitive Outcomes in Orthopedic Surgery
NCT07113483
The Efficacy and Safety of Remimazolam Besylate for Cardiac Anesthesia
NCT06717945
Efficacy and Safety of Remimazolam (CNS7056) Compared to Propofol for Intravenous Anesthesia During Elective Surgery
NCT03661489
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Propofol
Induction: Propofol, fentanyl, rocuronium. Maintenance: Sevoflurane, remifentanil.
Propofol
Sevoflurane
Remifentanil
Fentanyl
Rocuronium
Remimazolam 6 mg/kg/hr
Induction: Remimazolam 6 mg/kg/hr, fentanyl, rocuronium. Maintenance: Remimazolam up to 2 mg/kg/hr titrated to effect, remifentanil.
Remimazolam
Remifentanil
Fentanyl
Rocuronium
Remimazolam 12 mg/kg/hr
Induction: Remimazolam 12 mg/kg/hr, fentanyl, rocuronium. Maintenance: Remimazolam up to 2 mg/kg/hr titrated to effect, remifentanil.
Remimazolam
Remifentanil
Fentanyl
Rocuronium
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Remimazolam
Propofol
Sevoflurane
Remifentanil
Fentanyl
Rocuronium
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* scheduled for mechanical ventilation via tracheal intubation.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aptiv Solutions
INDUSTRY
Paion UK Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stefan Probst, MD
Role: PRINCIPAL_INVESTIGATOR
Heart Center Leipzig - University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Herzzentrum Leipzig GmbH
Leipzig, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-001113-32
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
CNS7056-010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.